What Did the Research Find
Additionally, the study found that weight gain after stopping was strongly associated with reinitiation, suggesting that many patients may need long-term therapy to maintain weight loss. The researchers concluded more studies are needed to explore how long-term health outcomes are tied to GLP-1 discontinuation and to assess how interventions financial barriers to the drugs and mitigate adverse events
The generics and biosimilar race
Some people choose to use the treatment to treat spots and blemishes on their skin, scars, skin discoloration, and even sun damage
Consequently, the insulin response to physiological GLP-1 in diabetic patients is diminished
Stephens FB, Evans CE, Constantin-Teodosiu D, Greenhaff PL